GLP-1 Without Insurance: How Cash-Pay Telehealth Works
The short answer
Yes — you can get GLP-1 medication without insurance through cash-pay telehealth. The cost depends on the path: brand-name products list around $1,060-$1,350 per month, while compounded GLP-1 through cash-pay telehealth typically runs $169-$399 per month, with Surfbound Health at a flat $169 for semaglutide or $219 for tirzepatide, provider review included and no membership fee. Eligibility and prescribing are never automatic — a licensed healthcare provider must evaluate your health history before any prescription is written.
Next step
Compare total recurring cost, not the headline price
The real cost of GLP-1 treatment includes provider fees, membership fees, shipping, and dose increases, not just the first month price. Surfbound uses flat cash-pay pricing with no membership fee, so your monthly cost stays predictable across dose levels.
- Flat cash-pay pricing with no membership fee
- Provider review included, no separate consultation fee
- Medication and shipping included when prescribed
- Month-to-month, no multi-month prepayment required
Fast, discreet shipping included when prescribed.
Payment options: The one-month plan is billed one month at a time. Optional 3- and 6-month supplies are prepaid; their total charge differs from three or six monthly payments. Compare the plan totals before choosing.
Who provides care: Surfbound Health is a trade name of Open Water Rx LLC. Licensed providers decide whether to prescribe; a dispensing pharmacy supplies medication if prescribed. Pharmacy information · State availability · Refund terms.
Treatment requires a licensed-provider review. Prescriptions are not guaranteed. Compounded medications are not FDA-approved.
Most people do not pay list price for brand-name GLP-1 medications — but many also do not have coverage for weight loss medications at all. Understanding the real options matters, because the difference between the most expensive path and the least expensive can be several hundred dollars every month. For a broader look at how these numbers are built, see our GLP-1 cost guide.
Why insurance coverage is so inconsistent
Insurance coverage for weight loss medications — as distinct from diabetes — remains inconsistent across employer plans: many plans exclude weight loss drugs entirely, and even when coverage exists, prior authorization, step therapy, and quantity limits are common, while coverage for diabetes indications (Ozempic, Mounjaro) is generally broader than for weight loss (Wegovy, Zepbound).
This is a coverage-policy reality, not a medical one. GLP-1 medications are FDA-approved for chronic weight management at a BMI of 30 or higher, or 27 or higher with a weight-related condition — regardless of whether you have diabetes. But your insurer may only cover the same active ingredient when it is prescribed for diabetes. That gap between medical appropriateness and insurance coverage is exactly why cash-pay options exist.
The brand-name path without insurance
Without coverage, brand-name GLP-1 list prices are approximately $1,350 per month for Wegovy (semaglutide) and $1,060 per month for Zepbound (tirzepatide) — and manufacturer savings programs, which typically reduce out-of-pocket cost to $550-$650 per month for commercially insured patients, do not apply to people on government insurance such as Medicare or Medicaid.
These list prices reflect FDA-approved products with extensive clinical trial data and FDA-inspected manufacturing. The value is real — but so is the cost. If you do not have commercial insurance or a savings program, paying over $1,000 a month out of pocket is simply not feasible for most people.
The Medicare shift
Historically, Medicare was prohibited by statute from covering weight loss medications. That has begun to change: CMS finalized rules that permit Medicare Part D plans to cover GLP-1 medications for weight loss when prescribed for beneficiaries with a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity. Coverage is not automatic — individual Part D plans retain formulary discretion, and prior authorization or step therapy may apply — but it represents a meaningful shift for Medicare beneficiaries who previously had no coverage path.
The cash-pay telehealth path
For people without insurance coverage, compounded GLP-1 medication through a cash-pay telehealth platform is the most affordable access pathway — typically $169-$399 per month with the provider review bundled into the price, rather than billed separately as it often is with a pharmacy-only or in-person route.
Compounded GLP-1 medications are prepared by licensed compounding pharmacies and are not FDA-approved — the FDA does not review compounded drugs for safety, effectiveness, or quality before they reach patients. That is an important distinction from brand-name products, and it is part of why the price is lower. It does not mean the medication is inherently unsafe; it means the regulatory oversight is different, and you should verify that your platform uses licensed pharmacies and discloses this clearly. Our compounded vs brand-name guide walks through the trade-offs.
The cash-pay line items: what to check before you pay
Within cash-pay telehealth, the advertised medication price is rarely the whole story. The same medication can be offered at very different true costs depending on how a platform bundles — or unbundles — the rest of the transaction. Before you pay, itemize these.
- Provider or consultation fees — whether the medical review is included in the program price, or billed as a separate one-time or recurring fee
- Membership or subscription fees — whether a monthly fee is layered on top of the medication, and whether it auto-renews
- Shipping and supplies — whether shipping, syringes, and a sharps container are included or added per shipment
- Dose-based pricing — whether the price rises as your dose is titrated up, or stays flat across dose levels
- Prepayment — whether you are charged before a provider reviews your health history, and what protects you if treatment is not approved
- Refunds and cancellation — what you get back if treatment is not prescribed, and how to cancel without minimum commitments or penalties
Prepayment and refunds deserve the most attention, because they are where a cash-pay patient carries the most financial risk. Some platforms collect payment at checkout, before any provider has reviewed your health history — meaning your money may be tied up, or non-refundable, if the provider later determines treatment is not appropriate. Others only charge after approval. Cancellation terms vary just as widely: some platforms are month-to-month with no penalty, while others impose minimum commitments or make canceling difficult. Confirm both the prepayment structure and the cancellation-and-refund terms in writing before you enter payment details.
Why Surfbound May Be a Good Fit for Cash-Pay Patients
Surfbound operates on a cash-pay model by design, which means there is no prior authorization, no coverage denial, and no surprise bill. The pricing is flat and disclosed upfront.
- Compounded semaglutide: $169 per month, across all dose levels
- Compounded tirzepatide: $219 per month, across all dose levels
- Provider review included — a licensed clinician reviews your health history before any prescription, and that review is part of the program price, not a separate fee
- No membership or subscription fee, and no insurance required
- Medication and shipping included when a prescription is issued
- The monthly price does not increase as your dose is titrated up within a treatment plan
For context, at $169 per month, a full year of compounded semaglutide is about $2,028 — roughly the cost of one to two months of brand-name Wegovy at list price. That is the core of the cash-pay value proposition, and it is why the model exists in the first place.
A low headline price is rarely the whole story. This shows each provider's medication "from" price and its membership as separate line items — we do not sum them into a single "effective total," because the real total depends on your dose, your state, and whether medication is even included in the membership.
MembershipNone
One flat price — medication, provider review, and shipping included when prescribed.
Membership$0 first month (eligible new subscribers), then $79/mo
Medication and membership are two separate charges; the total varies by dose and state. $139 ($60 + $79) is arithmetic, not a universal all-in quote.
Membership$39 first month, then $149/mo
Brand-name medication (not compounded), and medication is billed separately from membership.
Membership$39 first month, then $149/mo ($74/mo with annual prepay)
The membership does not include medication, so no all-in total is stated.
Medication "from" prices and membership terms checked 2026-10-03 from first-party sources. A starting price may not be your ongoing price. Compounded medications are not FDA-approved. Surfbound charges no membership fee.
Using HSA and FSA funds
Prescribed GLP-1 medication — including compounded versions obtained through telehealth — is generally a qualified medical expense for HSA and FSA reimbursement, because eligibility under IRS rules turns on whether the medication is prescribed by a licensed provider, not whether it is FDA-approved.
Using pre-tax HSA or FSA dollars effectively reduces your cost by your marginal tax rate — about 20-40% depending on your bracket. You may need a Letter of Medical Necessity from your provider for FSA reimbursement, and you should keep your prescription and pharmacy receipts for documentation. Our HSA and FSA guide covers the details.
How to compare your options
- Check your insurance formulary first — if weight loss medications are covered, brand-name may be cheapest after prior authorization
- If not covered, ask whether a manufacturer savings program applies (commercial insurance only)
- Compare cash-pay telehealth on total monthly cost including all fees — not just the headline price
- Confirm whether the provider review, membership, and shipping are included or separate
- Factor in HSA/FSA eligibility, which applies to prescribed medication across all of these paths
Ready to take the next step?
See Surfbound pricing and start your intakeFrequently asked questions
It ranges widely. Brand-name list prices are around $1,060-$1,350 per month; manufacturer savings programs may reduce that to $550-$650 for commercially insured patients; and compounded GLP-1 through cash-pay telehealth typically runs $169-$399 per month. Surfbound prices compounded semaglutide at $169 per month and tirzepatide at $219 per month, with the provider review included.
Yes, substantially. Compounded semaglutide at $169 per month is roughly one-eighth the list price of brand-name Wegovy. The trade-off is that compounded medications are not FDA-approved and are prepared by licensed compounding pharmacies, whereas brand-name products have FDA-reviewed clinical trial data.
Generally yes. Prescribed GLP-1 medication — including compounded versions — is typically a qualified medical expense for HSA and FSA reimbursement. You may need a Letter of Medical Necessity for FSA claims, and you should keep your prescription and receipts.
Coverage is now permitted but not automatic. CMS finalized rules allowing Medicare Part D plans to cover GLP-1 medications for weight loss at a BMI of 30 or higher, or 27 or higher with a weight-related condition. Individual plan formularies still determine actual coverage, and prior authorization or step therapy may apply.
Want more evidence-based health research from Surfbound?
Add Surfbound as a Preferred Source on Google